Building on the successful launch event in 2019, SynBio Markets 2021 will once again connect synthetic biology investors, academics and innovators to commercial end market customers across a variety of sectors. Focusing on investment and the commercial models essential to success, learn from industry leaders detailing what their technology has delivered and how they developed it, along with a unique insight into the challenges they have overcome and future opportunities they are focused on.
Unfortunately our business has been badly affected by Coronavirus and we have had to close the business and resolve to place the Company into liquidation. If you are a creditor the proposed liquidators will be in contact with you shortly. In the meantime, if you have any queries, please contact osman.khan@quantuma.com